217 related articles for article (PubMed ID: 8226154)
1. Non-Hodgkin's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group.
Tsang RW; Gospodarowicz MK; Sutcliffe SB; Sturgeon JF; Panzarella T; Patterson BJ
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):599-604. PubMed ID: 8226154
[TBL] [Abstract][Full Text] [Related]
2. Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma.
Belal AA; Allam A; Kandil A; El Husseiny G; Khafaga Y; Al Rajhi N; Ahmed G; Gray A; Ajarim D; Schultz H; Ezzat A
Am J Clin Oncol; 2001 Jun; 24(3):299-305. PubMed ID: 11404505
[TBL] [Abstract][Full Text] [Related]
3. Outcome analysis for stage IE and IIE thyroid lymphoma.
DiBiase SJ; Grigsby PW; Guo C; Lin HS; Wasserman TH
Am J Clin Oncol; 2004 Apr; 27(2):178-84. PubMed ID: 15057158
[TBL] [Abstract][Full Text] [Related]
4. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
5. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience.
Harrington KJ; Michalaki VJ; Vini L; Nutting CM; Syrigos KN; A'hern R; Harmer CL
Br J Radiol; 2005 May; 78(929):405-10. PubMed ID: 15845932
[TBL] [Abstract][Full Text] [Related]
6. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
[TBL] [Abstract][Full Text] [Related]
7. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
8. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases.
Colović M; Matić S; Kryeziu E; Tomin D; Colović N; Atkinson HD
Med Oncol; 2007; 24(2):203-8. PubMed ID: 17848745
[TBL] [Abstract][Full Text] [Related]
10. Localized extradural lymphoma: survival, relapse pattern and functional outcome. The Princess Margaret Hospital Lymphoma Group.
Rathmell AJ; Gospodarowicz MK; Sutcliffe SB; Clark RM
Radiother Oncol; 1992 May; 24(1):14-20. PubMed ID: 1620883
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
12. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
14. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
16. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study.
Onal C; Li YX; Miller RC; Poortmans P; Constantinou N; Weber DC; Atasoy BM; Igdem S; Ozsahin M; Ozyar E
Ann Oncol; 2011 Jan; 22(1):156-164. PubMed ID: 20587509
[TBL] [Abstract][Full Text] [Related]
17. Treatment of localized non-Hodgkin's lymphomas of the head and neck.
Ruijs CD; Dekker AW; van Kempen-Harteveld ML; van Baarlen J; Hordijk GJ
Cancer; 1994 Jul; 74(2):703-7. PubMed ID: 8033051
[TBL] [Abstract][Full Text] [Related]
18. Role of radiation therapy in localized non-Hodgkin's lymphoma.
Sutcliffe SB; Gospodarowicz MK; Bush RS; Brown TC; Chua T; Bean HA; Clark RM; Dembo A; Fitzpatrick PJ; Peters MV
Radiother Oncol; 1985 Nov; 4(3):211-23. PubMed ID: 3909240
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
